» Articles » PMID: 23043603

Hepatitis C Virus and Other Risk Factors in Hepatocellular Carcinoma

Overview
Journal Acta Virol
Specialty Microbiology
Date 2012 Oct 10
PMID 23043603
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Unlabelled: Hepatocellular carcinoma (HCC) increased in Egypt in the past years, becoming the most common cancer among men. Hepatitis B virus (HBV) and hepatitis C virus (HCV) are the known primary risk factors for HCC. This study describes the viral profile of HCC in a predominantly rural area in Egypt. We included 148 HCC cases and 148 controls from the Tanta Cancer Center and the Gharbiah Cancer Society in the Nile delta region. Serological (ELISA) and molecular (PCR) analysis for HBV and HCV infection were performed on plasma samples from each subject. Epidemiologic, environmental, and medical histories were collected by interviewing of subjects. Around 90.5% of cases and controls were from rural areas. HCV infection was high in both cases and controls (89.2% and 49.3%, for cases and controls respectively by serology). HCV was the most important HCC risk factor [OR 9.7 (95% CI: 3.3-28.0, P <0.01)], and HBV infection showed marginal tendency of increased risk [OR 5.4 (95% CI: 0.9-31.8, P <0.06)]. Ever worked in farming [OR 2.8 (95% CI: 1.1-7.2, P <0.03)] and history of cirrhosis [OR 3.6 (95% CI: 1.6-8.1, P <0.01)] or blood transfusion [OR 4.2 (95% CI: 0.99-17.8, P <0.05)] were also associated with increased HCC risk. This study in a predominantly rural area in Egypt supports previous reports from other parts of Egypt that HCV infection is the primary HCC risk factor in Egypt. Further understanding of the relationship between infection and other risk factors in the development of HCC could lead to targeted interventions for at-risk individuals.

Keywords: hepatocellular carcinoma; hepatitis; rural; risk factors; Egypt.

Citing Articles

Hepatitis B, C and D virus infections and risk of hepatocellular carcinoma in Africa: A meta-analysis including sensitivity analyses for studies comparable for confounders.

Mbaga D, Kenmoe S, Kengne-Nde C, Ebogo-Belobo J, Mahamat G, Rodrigue Foe-Essomba J PLoS One. 2022; 17(1):e0262903.

PMID: 35061846 PMC: 8782350. DOI: 10.1371/journal.pone.0262903.


Yttrium-90 microsphere radioembolisation for unresectable hepatocellular carcinoma.

Abdel-Rahman O, Elsayed Z Cochrane Database Syst Rev. 2020; 1:CD011313.

PMID: 31978267 PMC: 6984619. DOI: 10.1002/14651858.CD011313.pub3.


Pesticide exposure and liver cancer: a review.

VoPham T, Bertrand K, Hart J, Laden F, Brooks M, Yuan J Cancer Causes Control. 2017; 28(3):177-190.

PMID: 28194594 PMC: 5336347. DOI: 10.1007/s10552-017-0854-6.


Relative Importance of Hepatitis B and C Viruses in Hepatocellular Carcinoma in EMRO Countries and the Middle East: A Systematic Review.

Alavian S, Haghbin H Hepat Mon. 2016; 16(3):e35106.

PMID: 27226803 PMC: 4875504. DOI: 10.5812/hepatmon.35106.


Combination trans arterial chemoembolization (TACE) plus sorafenib for the management of unresectable hepatocellular carcinoma: a systematic review of the literature.

Abdel-Rahman O, Elsayed Z Dig Dis Sci. 2013; 58(12):3389-96.

PMID: 24046163 DOI: 10.1007/s10620-013-2872-x.


References
1.
Hassan M, Zaghloul A, El-Serag H, Soliman O, Patt Y, Chappell C . The role of hepatitis C in hepatocellular carcinoma: a case control study among Egyptian patients. J Clin Gastroenterol. 2001; 33(2):123-6. DOI: 10.1097/00004836-200108000-00006. View

2.
Hassan Z, Hafez M, Mansor T, Zekri A . Occult HBV infection among Egyptian hepatocellular carcinoma patients. Virol J. 2011; 8:90. PMC: 3058093. DOI: 10.1186/1743-422X-8-90. View

3.
Franceschi S, Raza S . Epidemiology and prevention of hepatocellular carcinoma. Cancer Lett. 2008; 286(1):5-8. DOI: 10.1016/j.canlet.2008.10.046. View

4.
Sievert W, Altraif I, Razavi H, Abdo A, Ahmed E, AlOmair A . A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt. Liver Int. 2011; 31 Suppl 2:61-80. DOI: 10.1111/j.1478-3231.2011.02540.x. View

5.
Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun M . Cancer statistics, 2009. CA Cancer J Clin. 2009; 59(4):225-49. DOI: 10.3322/caac.20006. View